Posts by Nicholas Alan Clayton
2026-07-30 at 8:14pm
Churchill Capital Corp XIII (NASDAQ:XIIIU) announced the pricing of its upsized $360 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "XIIIU" on Friday, July 31, 2026. ...
2026-07-30 at 10:36am
August brings a slate of much healthier de-SPACs to their lock-up expirations than has been seen in quite some time. Among the four de-SPACs, whose SPAC sponsor partners will be newly freed to trade stock this month, the average share price is about $6. ...
2026-07-30 at 8:28am
At the SPAC of Dawn Throughout early 2026, one of the encouraging trends for SPACs had been lower redemption rates at close for business combinations. After a difficult 2021-2024 period where any final redemption tally below 90% felt like a minor miracle, it has been heartening to see many deals close with negligible redemptions and the averages have dropped. ...
2026-07-29 at 8:27am
At the SPAC of Dawn D-Day has arrived for what could be new Fed Chair Kevin Warsh's first real movement on interest rates since officially taking office in May. Consensus expectations are for holding rates as is, but many expect a renewed hike could be in the cards eventually. ...
2026-07-28 at 1:16pm
Karman Line Acquisition Corp. Karman Line Acquisition Corp. (NASDAQ:XTERU) has filed for a $200 million SPAC aiming to join the wave of SPACs bringing the private space industry into the public markets. ...
2026-07-28 at 8:25am
At the SPAC of Dawn This summer has had a lumpy pace of SPAC business but the clusters have been quite exciting. In both June and now July there have been streaks of five business combinations announced within a five-day period and and the last time SPACs went five-for-five like that before was March 2023. ...
2026-07-27 at 8:47pm
Catalyst Acquisition Corp. (NASDAQ:CATLU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "CATLU" on Tuesday, July 28, 2026. ...
2026-07-27 at 3:59pm
Research Alliance III (NASDAQ:RACC) has entered into a definitive agreement to combine with drug developer Oak Hill Bio at a pro forma enterprise value of $193 million. Oak Hill Bio is developing a treatment for the rare genetic disease Angelman syndrome. ...
2026-07-27 at 1:04pm
Cartesian Growth II (OTC:RENEF) has entered into a definitive agreement to combine with energy storage firm InoBat at a $1.26 billion pre-money valuation, including earnout consideration. Slovakia-based InoBat produces utility-scale lithium ion battery storage systems for the data center industry and other clients. ...
2026-07-27 at 8:32am
At the SPAC of Dawn The final week of July stands to continue the month's busy stream of completing SPAC deals as three teams have scheduled special meetings to approve their business combinations over the next five days. ...